SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors weigh explosive Q2 earnings and strong guidance against the risks of high valuation and profit-taking ahead of potential volatility. While the community is divided between long-term believers in the AI memory supercycle and skeptics anticipating a post-earnings pullback, discussions remain focused on whether this performance justifies further upside or a technical correction.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing high volatility and increased retail interest as investors position themselves ahead of the company's upcoming earnings report. The community is actively debating the stock's valuation, the potential for a short squeeze, and the impact of broader drone industry momentum, while keeping a close watch on future defense contracts and guidance.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors grapple with a sharp decline in share price, which critics attribute to broader economic concerns and geopolitical instability, while the community remains deeply polarized over the company's long-term viability. Discourse is heavily driven by heated debates regarding the impact of recent administration policies on inflation and energy costs, fueling intense speculation about the stock's future and the political legacy of its founder.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending as investors aggressively drive the stock toward all-time highs, fueled by intense momentum, a low float, and speculation surrounding upcoming semiconductor earnings. The community is sharply divided between bullish traders chasing the breakout on strong AI-driven memory demand and skeptical investors warning of a potential bubble as the stock faces increased volatility ahead of major sector news.

DLocal Ltd. engages in the business of simplifying and redefining online payments experience. It focuses on processing payment transactions which enables merchants to get paid from customers and to make payments to customers in emerging markets. The company was founded by Andrés Bzurovski Bay and Sergio Enrique Fogel Kaplan in 2016 and is headquartered in Montevideo, Uruguay.

DLocal Limited - Ordinary Shares Class A

DLocal Limited

DLocal Limited is seeing a surge in investor interest following a strong earnings report that featured a revenue beat and the authorization of a significant share repurchase program. The community is actively discussing the stock's growth potential in emerging markets, with many debating the impact of the dividend announcement and debating the company's valuation relative to its aggressive expansion plans.

Five Below, Inc. operates as a specialty value retailer. It operates through the following segments: Leisure, Fashion and Home, and Party and Snack. The Leisure segment includes items such as sporting goods, games, toys, tech, books, electronic accessories, and arts and crafts. The Fashion and Home segment consists of personal accessories, “attitude” t-shirts, beauty offerings, home goods, and storage options. The Party and Snack segment offers party and seasonal goods, greeting cards, candy, and other snacks and beverages. The company was founded by David Schlessinger and Thomas G. Vellios in January 2002 and is headquartered in Philadelphia, PA.

Five Below Inc

Five Below is experiencing significant volatility and trading activity following a quarterly earnings report that beat analyst expectations, despite ongoing concerns regarding potential tariff-related headwinds and supply chain costs. The community remains divided, with active discussions focusing on high-conviction options flow and conflicting sentiment between bullish investors betting on the company's long-term growth and bearish traders concerned about store saturation and margin compression.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate is experiencing a massive surge in volume and price as traders position for the upcoming PDUFA decision on its once-daily ADHD treatment, CTx-1301. The community is buzzing with high conviction around upcoming patent announcements and long-term commercialization prospects, though some debate the risks associated with the company's regulatory path and market competition.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market sentiment for the S&P 500 is overwhelmingly bearish as investors react to a combination of geopolitical instability in the Middle East, rising energy prices, and persistent inflation concerns following the latest FOMC commentary. Community members are actively debating the potential for a deeper market correction, with many expressing frustration over policy uncertainty and the impact of the ongoing conflict on the broader economy.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) remains a volatile center of investor attention as markets react to escalating energy infrastructure attacks in the Middle East and ongoing uncertainty regarding shipping through the Strait of Hormuz. Community discussion is sharply divided between those betting on continued price spikes driven by supply-side instability and others anticipating a correction, as participants debate the impact of potential diplomatic intervention versus the long-term economic fallout of sustained supply disruptions.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is surging as investors capitalize on a confluence of catalysts, most notably the escalating geopolitical conflict in the Middle East which has effectively halted critical LNG shipments through the Strait of Hormuz and led to force majeure declarations in Qatar. The community is actively discussing the company's aggressive expansion, significant project financing wins, and its unique ability to capture windfall profits from the resulting spike in global spot market gas prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eventide Asset Management LLC Has $48.10 Million Stock Holdings in Celldex Therapeutics, Inc. $CLDX

Eventide Asset Management LLC raised its stake in Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) by 37.1% in the 3rd quarter, according to the company in its most recent disclosure with the...

Celldex Therapeutics, Inc. $CLDX Shares Sold by Commodore Capital LP

Commodore Capital LP trimmed its stake in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) by 12.2% during the 3rd quarter, according to the company in its most recent Form 13F filing...

Braidwell LP Makes New Investment in Celldex Therapeutics, Inc. $CLDX

Braidwell LP bought a new stake in Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange...

Celldex Therapeutics Touts Barzolvolimab Phase III CSU Momentum, Lays Out 2026 Data Catalysts

Celldex Therapeutics (NASDAQ:CLDX) executives highlighted recent clinical progress and upcoming catalysts during a discussion at the Leerink Partners Global Healthcare Conference, with a major focus...

Celldex Therapeutics, Inc. $CLDX Shares Purchased by American Century Companies Inc.

American Century Companies Inc. lifted its position in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) by 4.6% in the 3rd quarter, according to its most recent disclosure with the...

Celldex Therapeutics (NASDAQ:CLDX) Sets New 12-Month High - Still a Buy?

Celldex Therapeutics (NASDAQ:CLDX) Hits New 52-Week High - Time to Buy...

Celldex Therapeutics Highlights Barzolvolimab Phase 3 Wins, New Trials at TD Cowen Conference

Executives from Celldex Therapeutics (NASDAQ:CLDX) outlined a busy year of clinical and development milestones at the TD Cowen Healthcare Conference, highlighting completed enrollments in two Phase 3...

TD Asset Management Inc Decreases Stake in Celldex Therapeutics, Inc. $CLDX

TD Asset Management Inc cut its position in Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) by 27.7% during the third quarter, according to the company in its most recent 13F filing with the...

Propel Bio Management LLC Makes New $4.01 Million Investment in Celldex Therapeutics, Inc. $CLDX

Propel Bio Management LLC bought a new stake in Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) during the third quarter, according to the company in its most recent 13F filing with the...

Segall Bryant & Hamill LLC Buys 140,709 Shares of Celldex Therapeutics, Inc. $CLDX

Segall Bryant & Hamill LLC boosted its position in Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) by 36.3% during the 3rd quarter, according to the company in its most recent Form 13F filing...

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Current Price	$28.54
Prev Close	$29.64
Open	$29.38
Dividend Yield	0.00%
50-Day Moving Average	$26.57
Beta	1.14
Avg. Volume	956,330.66
PE Ratio	-7.61

52-Week High	$31.99
52-Week Low	$14.40
Market Capitalization	$1.97B
EPS (Annual)	-$3.90
Price to Book	3.74
Revenue Per Employee	$7,803.03

CLDX
Celldex Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CLDX News

CLDXCelldex Therapeutics Inc.